vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and Vishay Precision Group, Inc. (VPG). Click either name above to swap in a different company.
Vishay Precision Group, Inc. is the larger business by last-quarter revenue ($84.4M vs $60.1M, roughly 1.4× RHYTHM PHARMACEUTICALS, INC.). On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 17.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs 4.4%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
Vishay Intertechnology, Inc. is an American manufacturer of discrete semiconductors and passive electronic components founded by Polish-born businessman Felix Zandman. Vishay has manufacturing plants in Israel, Asia, Europe, and the Americas where it produces rectifiers, diodes, MOSFETs, optoelectronics, selected integrated circuits, resistors, capacitors, and inductors. Vishay Intertechnology revenues for 2024 were $2.9 billion. At the end of 2024, Vishay had approximately 22,700 full-time e...
RYTM vs VPG — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $60.1M | $84.4M |
| Net Profit | $-55.6M | — |
| Gross Margin | 88.1% | 39.0% |
| Operating Margin | -87.1% | — |
| Net Margin | -92.6% | — |
| Revenue YoY | 83.8% | 17.6% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.83 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $60.1M | $84.4M | ||
| Q4 25 | $57.3M | $80.6M | ||
| Q3 25 | $51.3M | $79.7M | ||
| Q2 25 | $48.5M | $75.2M | ||
| Q1 25 | $32.7M | $71.7M | ||
| Q4 24 | $41.8M | $72.7M | ||
| Q3 24 | $33.3M | $75.7M | ||
| Q2 24 | $29.1M | $77.4M |
| Q1 26 | $-55.6M | — | ||
| Q4 25 | $-47.5M | $-1.9M | ||
| Q3 25 | $-52.9M | $7.9M | ||
| Q2 25 | $-46.6M | $248.0K | ||
| Q1 25 | $-49.5M | $-942.0K | ||
| Q4 24 | $-43.3M | $688.0K | ||
| Q3 24 | $-43.6M | $-1.4M | ||
| Q2 24 | $-32.3M | $4.6M |
| Q1 26 | 88.1% | 39.0% | ||
| Q4 25 | 91.6% | 36.8% | ||
| Q3 25 | 89.3% | 40.3% | ||
| Q2 25 | 88.6% | 40.7% | ||
| Q1 25 | 88.8% | 37.7% | ||
| Q4 24 | 90.9% | 38.2% | ||
| Q3 24 | 88.5% | 40.0% | ||
| Q2 24 | 89.9% | 41.9% |
| Q1 26 | -87.1% | — | ||
| Q4 25 | -82.2% | 1.3% | ||
| Q3 25 | -102.6% | 12.7% | ||
| Q2 25 | -93.4% | 3.6% | ||
| Q1 25 | -143.7% | -0.1% | ||
| Q4 24 | -98.6% | 0.3% | ||
| Q3 24 | -132.0% | 5.1% | ||
| Q2 24 | -139.2% | 7.6% |
| Q1 26 | -92.6% | — | ||
| Q4 25 | -83.0% | -2.4% | ||
| Q3 25 | -103.1% | 9.9% | ||
| Q2 25 | -96.1% | 0.3% | ||
| Q1 25 | -151.4% | -1.3% | ||
| Q4 24 | -103.6% | 0.9% | ||
| Q3 24 | -131.2% | -1.8% | ||
| Q2 24 | -110.9% | 6.0% |
| Q1 26 | $-0.83 | — | ||
| Q4 25 | $-0.73 | $-0.14 | ||
| Q3 25 | $-0.82 | $0.59 | ||
| Q2 25 | $-0.75 | $0.02 | ||
| Q1 25 | $-0.81 | $-0.07 | ||
| Q4 24 | $-0.71 | $0.06 | ||
| Q3 24 | $-0.73 | $-0.10 | ||
| Q2 24 | $-0.55 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $340.6M | $82.5M |
| Total DebtLower is stronger | — | $20.6M |
| Stockholders' EquityBook value | $122.9M | $334.5M |
| Total Assets | $442.3M | $453.8M |
| Debt / EquityLower = less leverage | — | 0.06× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $340.6M | $82.5M | ||
| Q4 25 | $388.9M | $87.4M | ||
| Q3 25 | $416.1M | $86.3M | ||
| Q2 25 | $291.0M | $90.4M | ||
| Q1 25 | $314.5M | — | ||
| Q4 24 | $320.6M | $79.3M | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — |
| Q1 26 | — | $20.6M | ||
| Q4 25 | — | $20.6M | ||
| Q3 25 | — | $20.6M | ||
| Q2 25 | — | $31.5M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $31.4M | ||
| Q3 24 | — | $31.4M | ||
| Q2 24 | — | $31.9M |
| Q1 26 | $122.9M | $334.5M | ||
| Q4 25 | $139.1M | $336.4M | ||
| Q3 25 | $148.8M | $337.8M | ||
| Q2 25 | $-11.9M | $331.2M | ||
| Q1 25 | $18.9M | $325.0M | ||
| Q4 24 | $21.7M | $322.0M | ||
| Q3 24 | $11.2M | $330.6M | ||
| Q2 24 | $39.3M | $327.0M |
| Q1 26 | $442.3M | $453.8M | ||
| Q4 25 | $480.2M | $455.9M | ||
| Q3 25 | $506.9M | $462.3M | ||
| Q2 25 | $372.7M | $465.6M | ||
| Q1 25 | $386.7M | $453.8M | ||
| Q4 24 | $392.3M | $450.9M | ||
| Q3 24 | $363.6M | $462.5M | ||
| Q2 24 | $381.8M | $462.8M |
| Q1 26 | — | 0.06× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.06× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RYTM
Segment breakdown not available.
VPG
| Sensors segment | $33.3M | 39% |
| Weighing Solutions segment | $30.2M | 36% |
| Measurement Systems segment | $20.8M | 25% |
